Literature DB >> 33386990

Exploring the experience of recurrence with advanced cancer for people who perceived themselves to be cancer free: a grounded theory study.

Denice Economou1, Catherine Walshe2, Sarah G Brearley2.   

Abstract

PURPOSE: Advances in cancer treatment have led to longer cancer-free periods and overall survival. This study aimed to understand patients' experiences of transitioning out of a state of believing to be cancer free into incurable recurrence with advanced disease.
METHODS: Using constructivist grounded theory with in-depth interviews patients (n = 15) with solid tumors from a major US cancer center participated. Theoretical sampling enabled concepts to be developed until theme saturation. Constant comparative analysis used initial and focused coding to develop themes and concepts to describe this specific period from extended time cancer free and transition to advanced incurable disease.
RESULTS: Three interrelated concepts were identified: reluctant acceptance, seeking survival through continuous treatment, and hope in the face of an uncertain future. A conceptual model of the experience was developed encompassing anger and sadness, at initial recurrence, to reluctant acceptance, and, finally, a cycle of seeking continuous treatment to prolong life leading to a sense of hope in the face of an uncertain future.
CONCLUSION: The cycle between treatment and hope creates a state of personal equilibrium, which provides insights into the importance of treatment for this population. This study provides direction for future research to understand the expectations of people experiencing advanced cancer recurrence. IMPLICATIONS FOR CANCER SURVIVORS: Many cancer survivors live with advanced cancer. Assessing their needs as they transition from survivor with no disease to survivor with advanced disease requires a new conceptualization of the experience which recognizes expectations and priorities for care of this patient group.

Entities:  

Keywords:  Advanced cancer; Advanced recurrence; Continuous treatment; Hope; Reluctant acceptance; Survival; Uncertainty

Year:  2021        PMID: 33386990     DOI: 10.1007/s00520-020-05956-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  28 in total

Review 1.  Optimizing treatment in recurrent epithelial ovarian cancer.

Authors:  Giacomo Corrado; Vanda Salutari; Eleonora Palluzzi; Maria Grazia Distefano; Giovanni Scambia; Gabriella Ferrandina
Journal:  Expert Rev Anticancer Ther       Date:  2017-11-06       Impact factor: 4.512

Review 2.  Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis.

Authors:  Kemel A Ghotme; George E Barreto; Valentina Echeverria; Janneth Gonzalez; Rosa H Bustos; Magdy Sanchez; Jerzy Leszek; Nagendra Sastry Yarla; Rosa Margarita Gomez; Vadim V Tarasov; Ghulam Md Ashraf; Gjumrakch Aliev
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

3.  When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence.

Authors:  Brittany Mutsaers; Georden Jones; Nicole Rutkowski; Christina Tomei; Caroline Séguin Leclair; Danielle Petricone-Westwood; Sébastien Simard; Sophie Lebel
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

4.  Experiences of return to work after treatment for extremital soft tissue or bone sarcoma: Between distraction and leaving the disease behind.

Authors:  Sofia C Zambrano; Attila Kollár; Jürg Bernhard
Journal:  Psychooncology       Date:  2020-03-02       Impact factor: 3.894

5.  Level and direction of hope in cancer patients: an exploratory longitudinal study.

Authors:  Michael Sanatani; Gil Schreier; Larry Stitt
Journal:  Support Care Cancer       Date:  2007-09-20       Impact factor: 3.603

6.  Risky business: medical discourse, breast cancer, and narrative.

Authors:  Elizabeth M Davis
Journal:  Qual Health Res       Date:  2008-01

7.  Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).

Authors:  Sabine D Brookman-May; Matthias May; Shahrokh F Shariat; Giacomo Novara; Richard Zigeuner; Luca Cindolo; Ottavio De Cobelli; Cosimo De Nunzio; Sascha Pahernik; Manfred P Wirth; Nicola Longo; Alchiede Simonato; Sergio Serni; Salvatore Siracusano; Alessandro Volpe; Giuseppe Morgia; Roberto Bertini; Orietta Dalpiaz; Christian Stief; Vincenzo Ficarra
Journal:  BJU Int       Date:  2013-07-25       Impact factor: 5.588

8.  Fear of cancer recurrence: A study of the experience of survivors of ovarian cancer.

Authors:  Jamie Kyriacou; Alexandra Black; Nancy Drummond; Joanne Power; Christine Maheu
Journal:  Can Oncol Nurs J       Date:  2017-07-01

9.  Projections of cancer prevalence in the United Kingdom, 2010-2040.

Authors:  J Maddams; M Utley; H Møller
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

10.  Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.

Authors:  A S Ahmad; N Ormiston-Smith; P D Sasieni
Journal:  Br J Cancer       Date:  2015-02-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.